Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
British Journal of Pharmacology
|
February 20, 2014
Does levosimendan act as a Ca<sup>2+</sup> sensitizer or PDE3 inhibitor?: Commentary on Orstavik et al., Br J Pharmacol 171: 5169-5181
Masao Endoh
Cardiovascular Research
|
February 19, 2008
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of beta1-adrenoceptors
Masao Endoh
Circulation Research
|
August 20, 2016
Cardiac α1-Adrenoceptors and Inotropy: Myofilament Ca2+ Sensitivity, Intracellular Ca2+ Mobilization, Signaling Pathway, and Pathophysiological Relevance
Masao Endoh
Clinical Calcium
|
January 7, 2006
[Cav channels and Ca2+ antagonists: recent advances in molecular characteristics and pharmacology]
Masao Endoh
Cardiovascular Drugs and Therapy
|
May 18, 2007
Basic and clinical characteristics of PDE 3 inhibitors as cardiotonic agents
Masao Endoh
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 5, 2008
Cardiac Ca2+ signaling and Ca2+ sensitizers
Masao Endoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 26, 2002
[Molecular mechanism of heart conduction system]
Kuniaki Ishii, Masao Endoh
Expert Opinion on Pharmacotherapy
|
October 25, 2006
Acute heart failure: inotropic agents and their clinical uses
Masao Endoh, Masatsugu Hori
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 17, 2002
Effects of OR-1896, a metabolite of levosimendan, on force of contraction and Ca2+ transients under acidotic condition in aequorin-loaded canine ventricular myocardium
Reiko Takahashi, Masao Endoh
British Journal of Pharmacology
|
June 14, 2005
Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium
Reiko Takahashi, Masao Endoh
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
British Journal of Pharmacology
|
February 20, 2014
Does levosimendan act as a Ca<sup>2+</sup> sensitizer or PDE3 inhibitor?: Commentary on Orstavik et al., Br J Pharmacol 171: 5169-5181
Masao Endoh
Cardiovascular Research
|
February 19, 2008
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of beta1-adrenoceptors
Masao Endoh
Circulation Research
|
August 20, 2016
Cardiac α1-Adrenoceptors and Inotropy: Myofilament Ca2+ Sensitivity, Intracellular Ca2+ Mobilization, Signaling Pathway, and Pathophysiological Relevance
Masao Endoh
Clinical Calcium
|
January 7, 2006
[Cav channels and Ca2+ antagonists: recent advances in molecular characteristics and pharmacology]
Masao Endoh
Cardiovascular Drugs and Therapy
|
May 18, 2007
Basic and clinical characteristics of PDE 3 inhibitors as cardiotonic agents
Masao Endoh
Circulation Journal : Official Journal of the Japanese Circulation Society
|
November 5, 2008
Cardiac Ca2+ signaling and Ca2+ sensitizers
Masao Endoh
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
July 26, 2002
[Molecular mechanism of heart conduction system]
Kuniaki Ishii, Masao Endoh
Expert Opinion on Pharmacotherapy
|
October 25, 2006
Acute heart failure: inotropic agents and their clinical uses
Masao Endoh, Masatsugu Hori
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
October 17, 2002
Effects of OR-1896, a metabolite of levosimendan, on force of contraction and Ca2+ transients under acidotic condition in aequorin-loaded canine ventricular myocardium
Reiko Takahashi, Masao Endoh
British Journal of Pharmacology
|
June 14, 2005
Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium
Reiko Takahashi, Masao Endoh
Page
of 4